Drawing for TARGET HEALTH

USPTO serial 78313401

TARGET HEALTH

Reviewed by CopyMark Law Group

Reg. 3156025Status 800Renewal
Filing date
Status date
Registration date
Oct 17, 2006
Examiner
KAZAZIAN, MICHAEL H
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with TARGET HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $2,600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth I. Kohn

Kenneth I. Kohn KOHN & ASSOCIATES, PLLCSUITE 41030500 NORTHWESTERN HWY.FARMINGTON HILLS, MI 48334

Goods and services

ClassDescriptionStatusFirst use
035Business auditing services, namely, performing pre-inspection goods manufacturing practices audits and assuring that user fee monies are submitted; biostatistics and data processing services; providing statistical information; performing statistical analyses; manufacturer representatives in the field of pharmaceuticalsACTIVE—
041Computer services, namely, providing online journals in fields of health and medicineACTIVE—
042Providing quality assurance services in the field of pharmaceuticals; reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; consulting services regarding food and drug law and regulation compliance, namely, preparing for and conducting meetings to discuss and negotiate development strategies, preparing and submitting documents and forms required by the FDA, preparing responses to FDA questions and warning letters, follow-up with FDA on post application submission questions, preparing for and conducting meetings with legal counsel, troubleshooting product and process issues, performing analytical methods development and validation, and designing and implementing safety and regulatory toxicology programs; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical products; medical and scientific research, namely, conducting clinical trials, specifically preparing protocols, case report forms and informed consent forms, performing qualification, initiation, monitoring and closeout visits, generating investigator study files, monitor drug supply, identifying study sites and managing investigator payments, and preparing clinical sites for FDA inspection; consultation in the fields of drug development, including working with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements, evaluating available and competitive technologies; product and process development services; technical writing for others, specifically, integrated clinical and statistical study reports and other regulatory manuscriptsACTIVE—
044Providing an on-line database for use in gathering and providing patient records and patient data via a global computer networkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 12, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 14, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jan 14, 2017RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 14, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 12, 2017EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 3, 2016PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Aug 1, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 11, 2016E89RTEAS SECTION 8 & 9 RECEIVED—
Sep 12, 2012NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED—
Sep 12, 2012C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 12, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 20, 2012E815TEAS SECTION 8 & 15 RECEIVED—
Oct 17, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 25, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2006NPUBNOTICE OF PUBLICATION—
Jun 6, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 31, 2006ALIEASSIGNED TO LIE—
May 15, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 15, 2005RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 12, 2005RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 8, 2004CNSLLETTER OF SUSPENSION MAILED—
Nov 8, 2004CNSLSUSPENSION LETTER WRITTEN—
Nov 5, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 20, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2004MAILPAPER RECEIVED—
May 11, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 26, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance